Cancer News
OncoLink Cancer News - HealthDay

UV-Independent Pathway ID'd in Those at Risk for Melanoma

Thursday, November 1, 2012 (Last Updated: 11/02/2012)

THURSDAY, Nov. 1 (HealthDay News) -- Mice with an inactivating mutation in the melanocortin 1 receptor (Mc1r) gene, which controls pigment production, have a phenotype similar to red hair/fair skin in humans; these mice have an increased risk of melanoma, even in the absence of ultraviolet radiation exposure, which may act by a mechanism of oxidative damage, according to a study published online Oct. 31 in Nature.

Devarati Mitra, from the Massachusetts General Hospital in Charlestown, and colleagues used genetically engineered mice carrying an inactivating mutation in the Mc1r gene and introduced a conditional, melanocyte-targeted allele of the most common melanoma oncoprotein, BRAFV600E to investigate ultraviolet-radiation-independent carcinogenesis.

The researchers found that, without providing additional gene aberrations or ultraviolet radiation exposure, there was a high incidence of invasive melanomas in these mice. Following introduction of an albino allele to ablate all pigment production on the Mc1re/e background, selective absence of pheomelanin synthesis was found to be protective against the development of melanoma. Compared with albino-Mc1re/e mouse skin, normal-Mc1re/e mouse skin was found to have significantly greater oxidative DNA and lipid damage.

"These data suggest that the pheomelanin pigment pathway produces ultraviolet-radiation-independent carcinogenic contributions to melanomagenesis by a mechanism of oxidative damage," the authors write. "Although protection from ultraviolet radiation remains important, additional strategies may be required for optimal melanoma prevention."

Full Text (subscription or payment may be required)

Specialties Hematology & Oncology

Copyright © 2012 HealthDay. All rights reserved.

I Wish You Knew

Getting through cancer treatment: tips from an oncology nurse

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More